Participation in clinical trials is an indicator of best practice models. Entities funding these important studies do not award trial site status to just any practice. Coordinators for trials apply rigorous evaluation standards to potential investigating physicians and participating sites prior to considering inclusion.
From the patient's perspective, clinical trials provide many benefits. Great attention is directed to those enrolled in a trial, and participation typically incorporates a significant safety net for rescue therapy should a protocol not prove effective clinically. The number of people that may benefit from information learned through clinical trials is untold. Medicine would be hopelessly behind were it not for these physician and patient supported studies.
Posterior Vitreous Detachment
A 6 month, Phase 2 Randomized, Double-masked, Placebo-controlled Multicenter Clinical Trial Designed to Evaluate the Safety and Efficacy of Luminate in inducing PVD in Subjects with Non-Proliferative Diabetic Retinopathy.
ClinicalTrials.gov Identifier: NCT02435862 / 08.2015-Current
Patient must be at least 45 years of age with Non-proliferative diabetic retinopathy of any severity with a) no PVD, b) stage 1 PVD or c) stage 2 PVD and no other retinal pathologies that could interfere with the measurements or conduct of this study.
Exclusions include: media opacities or abnormalities that would preclude observation of the retina, prior vitrectomy, Epiretinal membranes, vitreomacular adhesion, vitreomacular traction, or macular holes, Proliferative Diabetic Retinopathy, neovascular AMD, or retinal vascular occlusion, retinal detachment, High myopes > -8.00D, HgA1c > 12.0.
Enrollment status: CLOSED
For more information on this trial